Lyra Therapeutics (LYRA) Insider Trading & Ownership $10.68 +0.40 (+3.89%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$10.81 +0.13 (+1.25%) As of 06/18/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics (NASDAQ:LYRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.25%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$13.45MNumber OfInsiders Selling(Last 3 Years)0 Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYRA Insider Buying and Selling by Quarter Lyra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/10/2023Harlan WaksalInsiderBuy500$148.00$74,000.00 5/31/2023Nbvm Gp, LlcMajor ShareholderBuy36,108$121.50$4,387,122.00 5/31/2023Perceptive Advisors LlcDirectorBuy72,216$124.50$8,990,892.00 (Data available from 1/1/2013 forward) LYRA Insider Trading Activity - Frequently Asked Questions Who is on Lyra Therapeutics' Insider Roster? The list of insiders at Lyra Therapeutics includes Harlan Waksal, Nbvm Gp, Llc, and Perceptive Advisors Llc. Learn more on insiders at LYRA. What percentage of Lyra Therapeutics stock is owned by insiders? 3.25% of Lyra Therapeutics stock is owned by insiders. Learn more on LYRA's insider holdings. Which Lyra Therapeutics insiders have been buying company stock? The following insider purchased LYRA shares in the last 24 months: Harlan Waksal ($74,000.00). How much insider buying is happening at Lyra Therapeutics? Insiders have purchased a total of 500 LYRA shares in the last 24 months for a total of $74,000.00 bought. Lyra Therapeutics Key ExecutivesDr. Harlan W. Waksal M.D. (Age 71)Executive Chairman Compensation: $210.06kDr. Maria Palasis Ph.D. (Age 59)CEO, President & Director Compensation: $942.7kDr. John E. Bishop Ph.D. (Age 62)Chief Technology Officer Compensation: $662.9kDr. Carmichael S. Roberts Jr. (Age 55)Ph.D., Co-Founder Mr. Jason Cavalier (Age 51)CFO, Treasurer & Secretary Compensation: $464.11kMr. Ray KnoxVice President of OperationsMs. Ellen CavaleriSenior Vice President of Investor Relations & CommunicationsMr. Ronan P. O'Brien J.D. (Age 51)Chief Legal Officer Ms. Corinne Noyes (Age 56)Senior Vice President of Commercial Strategy & Market Development Compensation: $426.73kMs. Vineeta Belanger Ph.D.Senior Vice President of Clinical Affairs More Insider Trading Tools from MarketBeat Related Companies FONR Insider Trading SRTS Insider Trading INO Insider Trading TELA Insider Trading NSPR Insider Trading MLSS Insider Trading VANI Insider Trading CTSO Insider Trading ZYXI Insider Trading APYX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:LYRA) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LYRA Stock Free LYRA Stock Alerts